FDA Inspection 1114168 — Nippon Sanso Matheson, Inc.

Nippon Sanso Matheson, Inc. — FEI 3003730218

The FDA completed an inspection of Nippon Sanso Matheson, Inc. on December 19, 2019 in Richmond, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 19, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Richmond, CA (United States)

Citations

IDCFRDescription
203121 CFR 211.194(a)Complete test data included in records